[HTML][HTML] Cytokine storm and immunomodulation in COVID-19

P Rangappa - Indian Journal of Critical Care Medicine: Peer …, 2021 - ncbi.nlm.nih.gov
ABSTRACT COVID-19 has become a major pandemic in recent times. The exact
pathophysiology and understanding of cytokine storm and immunomodulation are evolving …

Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment

M Soy, G Keser, P Atagündüz, F Tabak… - Clinical …, 2020 - Springer
COVID-19 infection has a heterogenous disease course; it may be asymptomatic or causes
only mild symptoms in the majority of the cases, while immunologic complications such as …

The anti-inflammatory cytokine response characterized by elevated interleukin-10 is a stronger predictor of severe disease and poor outcomes than the pro …

BM Henry, SW Benoit, J Vikse, BA Berger… - Clinical Chemistry and …, 2021 - degruyter.com
Objectives Severe coronavirus disease 2019 (COVID-19) is associated with a dysregulated
immune state. While research has focused on the hyperinflammation, little research has …

Integrated immune dynamics define correlates of COVID-19 severity and antibody responses

M Koutsakos, LC Rowntree, L Hensen, BY Chua… - Cell Reports …, 2021 - cell.com
SARS-CoV-2 causes a spectrum of COVID-19 disease, the immunological basis of which
remains ill defined. We analyzed 85 SARS-CoV-2-infected individuals at acute and/or …

Cytokine storm and the prospects for immunotherapy with COVID-19.

LH Calabrese - Cleveland Clinic journal of medicine, 2020 - europepmc.org
Knowledge about the pathobiology of SARS-CoV-2 as it interacts with immune defenses is
limited. SARS-CoV-2 is spread by droplets that come into contact with mucous membranes …

[HTML][HTML] Monocytes and macrophages in severe COVID‐19–friend, foe or both?

RJ Dress, F Ginhoux - Immunology and Cell Biology, 2021 - ncbi.nlm.nih.gov
While most COVID-19 patients have mild symptoms, about 15% of patients develop severe
COVID-19 often with fatal outcomes, and scientists have been on the hunt to understand the …

[引用][C] COVID-19: a citokinviharon innen és túl...

Z Szekanecz, PV Bálint, A Balog, Z Barta, L Czirják… - Immunológiai Szemle, 2020 - szte

Modulating the host immune response to fight against COVID-19: Where are we in 2021?

DM Hertanto, H Sutanto, BS Wiratama, CDK Wungu - Virulence, 2021 - Taylor & Francis
At present, while some countries are dealing with the continuously increasing incidence,
some of the others are currently facing the 2019 coronavirus disease (COVID-19) …

Pathophysiological, immunological, and inflammatory features of long COVID

K Bohmwald, B Diethelm-Varela… - Frontiers in …, 2024 - frontiersin.org
The COVID-19 pandemic continues to cause severe global disruption, resulting in significant
excess mortality, overwhelming healthcare systems, and imposing substantial social and …

[HTML][HTML] Integrated analysis of circulating immune cellular and soluble mediators reveals specific COVID19 signatures at hospital admission with utility for prediction of …

I Uranga-Murillo, E Morte, S Hidalgo, C Pesini… - Theranostics, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID19), caused by SARS-CoV-2, is a complex
disease, with a variety of clinical manifestations ranging from asymptomatic infection or mild …